Valerio Therapeutics SA Sustainability Reports

Valerio Therapeutics S.A. is a clinical-stage biotechnology company that develops proprietary technology platforms for the targeted delivery of innovative therapies. Its systems include the PlatON, DecoyTAC, and V-Body platforms to advance early-stage compounds toward clinical proof-of-concept.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

ISIN: FR0010095596

8 reports from 2010 to 2023

• Valerio Therapeutics SA 2023 Full-Year Financial Report
• Valerio Therapeutics SA 2021 Annual Financial Report
• Valerio Therapeutics SA 2017 Registration Document
• Valerio Therapeutics SA 2016 Registration Document
• Valerio Therapeutics SA 2015 Reference Document